Brain metastases in japanese nsclc patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study

HIGHLIGHTS

• who: Hajime Higaki from the (UNIVERSITY) have published the research work: Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitorsu2014retrospective study, in the Journal: (JOURNAL)
• what: The aim of this study was to validate the robustness of Lung-molGPA with Japanese patients, as well as to assess the prognostic impact of the expression of PD-L1 (tumor factor) and the use of osimertinib and ICI (treatment factor). Although the authors could not evaluate the effect fully because this study had the small number of patients and included . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.